Thoracic Malignancy
We focus on improving the diagnosis, monitoring, and treatment of thoracic malignancies, with a primary emphasis on early detection, personalised treatment and risk reduction in lung cancer screening and mesothelioma.
Research Areas
- Mesothelioma Research and Clinical TrialsPragmatic clinical trials and the development of representative patient cohorts.
- Lung Cancer Screening (LCS)Optimising implementation, maximising the effectiveness and increasing participation in the national lung cancer screening programme.
- Smoking Cessation and Behaviour ChangeDeveloping and evaluating interventions to increase smoking cessation uptake and success and reduce inequalities in tobacco-related harm.